AMEGA Biotech

Last updated: 12.01.2015

amega_logoAMEGA Biotech is a biotechnology organization with a new vision on the production and commercialization of human biopharmaceuticals aimed at achieving the highest quality standards.

With a focus on competitiveness and time-to-market, structure of AMEGA Biotech allows control of all the manufacturing processes, from the Active Pharmaceutical Ingredient (API) to the Finished Dosage Form.

With a strong development platform and four production sites, AMEGA Biotech develops and produces biosimilars. Exporting recombinant proteins worldwide and focused on central markets registrations, AMEGA Biotech is the leading regional producer. At present, AMEGA Biotech products are available in markets such as the US, Brazil, Chile, Colombia, Uruguay, Mexico, Paraguay and Venezuela, Middle East (Egypt, Iran, Pakistan, Russia and Ukraine) and Southwest Asia (Singapore and Vietnam).

Parque Austral – Insignia Building M1
Avenida Sargento Cayetano Beliera 3025
B1629WWA | Pilar | Bs.As. | Argentina |
Phone: +54 230 438.5600



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here